Inhibition of miR-146a Expression and Regulation of Endotoxin Tolerance by Rhesus Theta-Defensin-1

Area of Science:

• Immunology
• Molecular Biology
• Peptide Science

Background:

• Theta-defensins, like rhesus theta-defensin-1 (RTD-1), are host defense peptides with immune-modulating functions.
• Lipopolysaccharide (LPS) stimulation activates inflammatory pathways via Toll-like receptor-4 (TLR4) and NF-κB signaling.
• Endotoxin tolerance is a state of reduced responsiveness to LPS following prolonged exposure, involving microRNA-146a (miR-146a) regulation of IRAK1 and TRAF6.

Purpose of the Study:

• To investigate the effect of RTD-1 on endotoxin tolerance in immune cells.
• To elucidate the role of RTD-1 in regulating miR-146a and associated inflammatory pathways.
• To determine if RTD-1 can reverse established endotoxin tolerance.

Main Methods:

• Monocytic THP-1 cells were stimulated with LPS and RTD-1.
• Expression levels of miR-146a and IRAK1 protein were analyzed.
• TNF-α secretion and NF-κB activity were measured following primary and secondary LPS challenges.
• RTD-1 dose-dependency was assessed.

Main Results:

• RTD-1 suppressed miR-146a expression and stabilized IRAK1 protein in LPS-stimulated cells.
• Cells treated with RTD-1 during primary LPS exposure did not develop endotoxin tolerance and secreted TNF-α upon secondary challenge.
• RTD-1 treatment during primary LPS stimulation led to increased NF-κB activity after secondary LPS challenge in a dose-dependent manner.

Conclusions:

• RTD-1 inhibits endotoxin tolerance by downregulating miR-146a and modulating the NF-κB pathway.
• RTD-1 demonstrates a novel inflammatory role by preventing the development of endotoxin tolerance during innate immune responses.
• RTD-1 may represent a therapeutic target for modulating inflammatory conditions associated with LPS exposure.